Pier 1 Imports, Inc. Adopts Short-Term Shareholder Rights Protection Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high, AI stocks rally
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Jefferies Raises price Target on Pier 1 Imports (PIR) Following 2Q Report
September 29, 2016 8:49 AM EDTJefferies reiterated a Hold rating on Pier 1 Imports (NYSE: PIR), and raised the price target to $4.50 (from $4.25), following the company's 2Q earnings report. Merchandise margins were in line with guidance on a more balanced promotional posture and improved distribution center efficiency.
Analyst... More
Alden 'Disappointed' in Pier 1 Imports' (PIR) Adoption of 10% Poison Pill
September 28, 2016 3:47 PM EDTAlden Global Capital LLC , the largest active shareholder of Pier 1 Imports, Inc. (NYSE: PIR), with ownership of approximately 9.5% of Pier 1's outstanding shares, issued a statement today in response to Pier 1's post-market announcement on September 27, 2016 that it has adopted a "poison pill" rights plan (the "Poison Pill") with a 10% ownership limitation. Alden is severely disappointed that Pier 1 has resorted to this highly questionable form of entrenchment rather than engage constructively with one of its largest shareholders.
Heath Freeman, President of Alden, stated, "We were incredibly surprised and disappointed to learn... More
